Associate Professor Samantha Fraser-Bell

Associate Professor
Clinical Ophthalmology &
Eye Health, the Save Sight Institute and Sydney Adventist Hospital Clinical School, Macula Research Group, SSI


Website Save Sight Institute

Map

Current research students

Project title Research student
Limitations of anti-VEGF therapy for the treatment of macular oedema. Kimberly SPOONER

Keywords

Retina; Ophthalmology

Clinical Specialty

Ophthalmology

Selected grants

2016

  • Phase 4, open-label, non-randomized, prospective study of OZURDEX� in the Treatment of Diabetic Macular Oedema � The AUSSIEDEX Study Owner: Save Sight; Fraser-Bell S; Quintiles Pty Ltd/Research Support.
  • A Phase IV randomised clinical trial of laser therapy for peripheral retinal ischaemia combined with intravitreal aflibercept (Eylea®) versus intravitreal aflibercept monotherapy for diabetic macular oedema (LADAMO) Owner: Save Sight; Fraser-Bell S; Bayer Australia Ltd/Research Support.
  • Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration; Fraser-Bell S; Allergan Australia Pty Ltd/Research Support.
  • A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients with Geographic Atrophy (GA) - FILLY Owner: Save Sight; Fraser-Bell S; Clinical Network Services (CNS) Pty Ltd/Research Grant.

2015

  • Managing neovascular age-related macular degeneration (nAMD) over 2 years with a Treat and Extend (T&E) regimen of 2 mg intravitreal aflibercept - a randomized, open-label, active-controlled, parallel-group phase IV/IIIb study (ARIES) Owner: Save Sight; Fraser-Bell S; Bayer Australia Ltd/Research Grants.
  • A two-year, randomised, double masked, multi-centre, three-arm study, comparing the efficacy and safety of RTH258 versus Aflibercept, in subjects with Neovascular age-related macular degeneration.; Fraser-Bell S; Alcon Laboratories (Australia) Pty Ltd/Research Support.
  • Randomised control trial of laser therapy for peripheral retinal ischaemia in diabetic macula oedema; Fraser-Bell S, Gillies M; Diabetes Australia Research Trust (DART)/Research Grants.

2010

  • Clinical trial of intravitreal injections of dexamethasone vs bevacizumab in diabetic foveal oedema resistant to laser; Gillies M, Kaines A, Fraser-Bell S; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Iglicki, M., Busch, C., Zur, D., Okada, M., Mariussi, M., Chhablani, J., Cebeci, Z., Fraser-Bell, S., Chaikitmongkol, V., Couturier, A., et al (2019). DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study. Retina, 39(1), 44-51. [More Information]
  • Nguyen, V., Daien, V., Guymer, R., Young, S., Hunyor, A., Fraser-Bell, S., Hunt, A., Gillies, M., Barthelmes, D. (2019). Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. Ophthalmology, 126(1), 64-74. [More Information]
  • Mehta, H., Hennings, C., Gillies, M., Nguyen, V., Campain, A., Fraser-Bell, S. (2018). Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database of Systematic Reviews, 2018 (4), 1-70. [More Information]
  • Hui, M., Raniga, A., Fraser-Bell, S., Salem, W., Clement, C. (2018). Comparison of ICare tonometry to Goldmann tonometry for the measurement of intraocular pressure changes following intravitreal anti-vascular endothelial growth factor injection. Clinical and Experimental Ophthalmology, 46(7), 821-823. [More Information]
  • Zur, D., Iglicki, M., Busch, C., Invernizzi, A., Mariussi, M., Loewenstei, A., Fraser-Bell, S. (2018). OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant. Ophthalmology, 125(2), 288-294. [More Information]
  • Busch, C., Zur, D., Fraser-Bell, S., Lains, I., Santos, A., Lupidi, M., Cagini, C., Gabrielle, P., Couturier, A., Mane-Tauty, V., et al (2018). Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetologica, 55(8), 789-796. [More Information]
  • Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. (2018). Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology, 102(4), 479-482. [More Information]
  • Teo, K., Gillies, M., Fraser-Bell, S. (2018). The use of vascular endothelial growth factor inhibitors and complementary treatment options in polypoidal choroidal vasculopathy: A subtype of neovascular age-related macular degeneration. International Journal of Molecular Sciences, 19(9), 1-14. [More Information]
  • Fraser-Bell, S., Symes, R., Vaze, A. (2017). Hypertensive eye disease: a review. Clinical and Experimental Ophthalmology, 45(1), 45-53. [More Information]
  • Wickremasinghe, S., Fraser-Bell, S., Alessandrello, E., Mehta, H., Gillies, M., Lim, L. (2017). Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema. British Journal of Ophthalmology, 101(10), 1329-1333. [More Information]
  • Fraser-Bell, S., Lim, L., Campain, A., Mehta, H., Aroney, C., Bryant, J., Li, J., Quin, G., McAllister, I., Gillies, M. (2016). Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology, 123(6), 1399-1401. [More Information]
  • Mehta, H., Gillies, M., Fraser-Bell, S. (2016). Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review. Clinical and Experimental Ophthalmology, 44(4), 335-339. [More Information]
  • Mehta, H., Fraser-Bell, S., Yeung, A., Campain, A., Lim, L., Quin, G., McAllister, I., Keane, P., Gillies, M. (2016). Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trial. British Journal of Ophthalmology, 100(7), 1000-1004. [More Information]
  • Aroney, C., Fraser-Bell, S., Lamoureux, E., Gillies, M., Lim, L., Fenwick, E. (2016). Vision-related quality of life outcomes in the BEVORDEX study: A clinical trial comparing ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Investigative Ophthalmology and Visual Science, 57(13), 5541-5546. [More Information]
  • Wong, E., Fraser-Bell, S., Hunyor, A., Chen, F. (2015). Novel optical coherence tomography classification of torpedo maculopathy. Clinical and Experimental Ophthalmology, 43(4), 342-348. [More Information]
  • Au, C., Fardell, N., Williams, M., Fraser-Bell, S., Campain, A., Gillies, M. (2015). Patient experiences in retinal trials: a cross-sectional study. BMC Ophthalmology, 15(1), 1-7. [More Information]
  • Mehta, H., Gillies, M., Fraser-Bell, S. (2015). Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema. Therapeutic Advances in Chronic Diseases, 6(5), 234-245. [More Information]
  • Gillies, M., Lim, L., Campain, A., Quin, G., Salem, W., Li, J., Goodwin, S., Aroney, C., McAllister, I., Fraser-Bell, S. (2014). A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema: The BEVORDEX Study. Ophthalmology, 121(12), 2473-2481. [More Information]
  • Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration. Acta Ophthalmologica, 92(8), e697-e698. [More Information]
  • Fraser-Bell, S. (2014). Preventing vision loss from advanced age-related macular degeneration. Clinical and Experimental Ophthalmology, 42(5), 409-410. [More Information]
  • Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration. Retina, 34(9), 1774-1778. [More Information]
  • Toniolo, J., Hall, A., Sims, J., Fraser-Bell, S., Khan, J., Younan, C., Kent-Smith, B., Young, S., Paul, E., Lim, L. (2014). Retrospective analysis of the natural history and management of serpiginous choroiditis in Australia and New Zealand. Clinical and Experimental Ophthalmology, 42(7), 656-664. [More Information]
  • Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013). Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical and Experimental Ophthalmology, 41(2), 201-214. [More Information]
  • Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013). Diagnosis and interventions for central serous chorioretinopathy: review and update. Clinical and Experimental Ophthalmology, 41(2), 187-200. [More Information]
  • Karim, R., Sykakis, E., Lightman, S., Fraser-Bell, S. (2013). Interventions for the treatment of uveitic macular edema: a systematic review and meta analysis. Clinical Ophthalmology, 7, 1109-1144. [More Information]
  • Rajendram, R., Fraser-Bell, S., Kaines, A., Michaelides, M., Hamilton, R., Degli Esposti, S., Peto, T., Egan, C., Bunce, C., Leslie, R., et al (2012). A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema: 24-Month Data: Report 3. Archives of Ophthalmology, 130(8), 972-979. [More Information]
  • Salem, W., Fraser-Bell, S., Gillies, M. (2012). Clinical development of new treatments for diabetic macular oedema. Clinical and Experimental Optometry, 95(3), 297-305. [More Information]
  • Fung, A., Azar, D., Fraser-Bell, S., McCluskey, P., Grigg, J. (2011). Ockham's razor revisited: decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension. BMJ Case Reports, 2011, bcr0520103030-bcr0520103030. [More Information]
  • Fung, A., Azar, D., Fraser-Bell, S., McCluskey, P., Grigg, J. (2011). Ockham's razor revisited: Decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension. BMJ Case Reports, 2011 (17 February 2011). [More Information]
  • Atan, D., Fraser-Bell, S., Plskova, J., Kuffova, L., Hogan, A., Tufail, A., Kilmartin, D., Forrester, J., Bidwell, J., Dick, A., et al (2011). Punctate inner choroidopathy and multifocal choroiditis with panuveitis share haplotypic associations with IL10 and TNF loci. Investigative Ophthalmology and Visual Science, 52(6), 3573-3581. [More Information]
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 1. Australian Doctor, 22, 27-32.
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 2. Australian Doctor, 29, 25-32.
  • Michaelides, M., Kaines, A., Hamilton, R., Fraser-Bell, S., Rajendram, R., Quhill, F., Boos, C., Xing, W., Egan, C., Peto, T., et al (2010). A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology, 117(6), 1078-1086. [More Information]
  • Atan, D., Fraser-Bell, S., Plskova, J., Kuffova, L., Hogan, A., Tufail, A., Kilmartin, D., Forrester, J., Bidwell, J., Dick, A., et al (2010). Cytokine polymorphism in noninfectious uveitis. Investigative Ophthalmology and Visual Science, 51(8), 4133-4142. [More Information]
  • Michaelides, M., Fraser-Bell, S., Hamilton, R., Kaines, A., Egan, C., Bunce, C., Peto, T. (2010). Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1. Retina: the Journal of Retinal and Vitreous Diseases, 30(5), 781-786. [More Information]
  • Fraser-Bell, S., Choudhury, F., Klein, R., Azen, S., Varma, R. (2010). Ocular Risk Factors for Age-Related Macular Degeneration: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 149(5), 735-740. [More Information]
  • Essex, R., Wong, J., Fraser-Bell, S., Sandbach, J., Tufail, A., Bird, A., Dowler, J. (2010). Punctate inner choroidopathy: Clinical Features and outcomes. Archives of Ophthalmology, 128(8), 982-987. [More Information]
  • Hooper, C., Lamoureux, E., Lim, L., Fraser-Bell, S., Yeoh, J., Harper, C., Keeffe, J., Guymer, R. (2009). Cataract surgery in high-risk age-related macular degeneration: A randomized controlled trial. Clinical and Experimental Ophthalmology, 37(6), 570-576. [More Information]
  • Fraser-Bell, S., Pavesio, C. (2008). Advances in the treatment of intermediate and posterior uveitis. Expert Review of Ophthalmology, 3(4), 449-456. [More Information]
  • Fraser-Bell, S., Wu, J., Klein, R., Azen, S., Hooper, C., Foong, A., Varma, R. (2008). Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. American Journal of Ophthalmology, 145(2), 308-316. [More Information]
  • Fraser-Bell, S., Kaines, A., Hykin, P. (2008). Update on treatments for diabetic macular edema. Current Opinion in Ophthalmology, 19(3), 185-189. [More Information]
  • Fung, A., Fraser-Bell, S., Ojaimi, E., Sutton, G. (2007). In vivo confocal microscopy and polarizing microscopy of the cornea in a patient with nephropathic cystinosis. Clinical and Experimental Ophthalmology, 35, 292-293. [More Information]
  • Hooper, C., Fraser-Bell, S., Farinelli, A., Grigg, J. (2006). Complicated hyphaema: think sickle. Clinical and Experimental Ophthalmology, 34(4), 377-378. [More Information]
  • Fraser-Bell, S., Wu, J., Klein, R., Azen, S., Varma, R., Latino Eye Study Group, L. (2006). Smoking, Alcohol Intake, Estrogen Use, and Age-related Macular Degeneration in Latinos: the Los Angeles Latino Eye Study. American Journal of Ophthalmology, 141(1), 79-87. [More Information]
  • De Moura, C., Fraser-Bell, S., Stout, A., Labree, L., Nilfors, M., Varma, R. (2005). Experience with the Baerveldt glaucoma implant in the management of pediatric glaucoma. American Journal of Ophthalmology, 139(5), 847-854. [More Information]
  • Shufelt, C., Fraser-Bell, S., Ying-Lai, M., Torres, M., Varma, R., Los Angeles Latino Eye Study Group, -. (2005). Refractive error, ocular biometry, and lens opalescence in an adult population: The Los Angeles Latino Eye Study. Investigative Ophthalmology and Visual Science, 46(12), 4450-4460. [More Information]
  • Fraser-Bell, S., Donofrio, J., Wu, J., Klein, R., Azen, S., Varma, R., Los Angeles Latino Eye Study Group, -. (2005). Sociodemographic factors and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 139(1), 30-38. [More Information]
  • Fraser-Bell, S., Ying-Lai, M., Klein, R., Varma, R., Los Angeles Latino Eye Study Group, -. (2004). Prevalence and Associations of Epiretinal Membranes in Latinos: The Los Angeles Latino Eye Study. Investigative Ophthalmology and Visual Science, 45(6), 1732-1736. [More Information]
  • Varma, R., Fraser-Bell, S., Tan, S., Klein, R., Azen, S., Los Angeles Latino Eye Study Group, -. (2004). Prevalence of age-related macular degeneration in Latinos: The Los Angeles Latino eye study. Ophthalmology, 111(7), 1288-1297. [More Information]
  • Guzowski, M., Fraser-Bell, S., Rochtchina, E., Wang, J., Mitchell, P. (2003). Asymmetric refraction in an older population: the Blue Mountains Eye Study. American Journal of Ophthalmology, 136(3), 551-553. [More Information]
  • Fraser-Bell, S., Varma, R. (2003). Eye Disease in Latinos. International Ophthalmology Clinics, 43(4), 79-89. [More Information]
  • Fraser-Bell, S., Guzowski, M., Rochtchina, E., Wang, J., Mitchell, P. (2003). Five-year cumulative incidence and progression of epiretinal membranes. Ophthalmology, 110(1), 34-40. [More Information]

2019

  • Iglicki, M., Busch, C., Zur, D., Okada, M., Mariussi, M., Chhablani, J., Cebeci, Z., Fraser-Bell, S., Chaikitmongkol, V., Couturier, A., et al (2019). DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study. Retina, 39(1), 44-51. [More Information]
  • Nguyen, V., Daien, V., Guymer, R., Young, S., Hunyor, A., Fraser-Bell, S., Hunt, A., Gillies, M., Barthelmes, D. (2019). Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. Ophthalmology, 126(1), 64-74. [More Information]

2018

  • Mehta, H., Hennings, C., Gillies, M., Nguyen, V., Campain, A., Fraser-Bell, S. (2018). Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database of Systematic Reviews, 2018 (4), 1-70. [More Information]
  • Hui, M., Raniga, A., Fraser-Bell, S., Salem, W., Clement, C. (2018). Comparison of ICare tonometry to Goldmann tonometry for the measurement of intraocular pressure changes following intravitreal anti-vascular endothelial growth factor injection. Clinical and Experimental Ophthalmology, 46(7), 821-823. [More Information]
  • Zur, D., Iglicki, M., Busch, C., Invernizzi, A., Mariussi, M., Loewenstei, A., Fraser-Bell, S. (2018). OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant. Ophthalmology, 125(2), 288-294. [More Information]
  • Busch, C., Zur, D., Fraser-Bell, S., Lains, I., Santos, A., Lupidi, M., Cagini, C., Gabrielle, P., Couturier, A., Mane-Tauty, V., et al (2018). Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetologica, 55(8), 789-796. [More Information]
  • Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. (2018). Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology, 102(4), 479-482. [More Information]
  • Teo, K., Gillies, M., Fraser-Bell, S. (2018). The use of vascular endothelial growth factor inhibitors and complementary treatment options in polypoidal choroidal vasculopathy: A subtype of neovascular age-related macular degeneration. International Journal of Molecular Sciences, 19(9), 1-14. [More Information]

2017

  • Fraser-Bell, S., Symes, R., Vaze, A. (2017). Hypertensive eye disease: a review. Clinical and Experimental Ophthalmology, 45(1), 45-53. [More Information]
  • Wickremasinghe, S., Fraser-Bell, S., Alessandrello, E., Mehta, H., Gillies, M., Lim, L. (2017). Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema. British Journal of Ophthalmology, 101(10), 1329-1333. [More Information]

2016

  • Fraser-Bell, S., Lim, L., Campain, A., Mehta, H., Aroney, C., Bryant, J., Li, J., Quin, G., McAllister, I., Gillies, M. (2016). Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology, 123(6), 1399-1401. [More Information]
  • Mehta, H., Gillies, M., Fraser-Bell, S. (2016). Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review. Clinical and Experimental Ophthalmology, 44(4), 335-339. [More Information]
  • Mehta, H., Fraser-Bell, S., Yeung, A., Campain, A., Lim, L., Quin, G., McAllister, I., Keane, P., Gillies, M. (2016). Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: Data from the BEVORDEX randomised clinical trial. British Journal of Ophthalmology, 100(7), 1000-1004. [More Information]
  • Aroney, C., Fraser-Bell, S., Lamoureux, E., Gillies, M., Lim, L., Fenwick, E. (2016). Vision-related quality of life outcomes in the BEVORDEX study: A clinical trial comparing ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Investigative Ophthalmology and Visual Science, 57(13), 5541-5546. [More Information]

2015

  • Wong, E., Fraser-Bell, S., Hunyor, A., Chen, F. (2015). Novel optical coherence tomography classification of torpedo maculopathy. Clinical and Experimental Ophthalmology, 43(4), 342-348. [More Information]
  • Au, C., Fardell, N., Williams, M., Fraser-Bell, S., Campain, A., Gillies, M. (2015). Patient experiences in retinal trials: a cross-sectional study. BMC Ophthalmology, 15(1), 1-7. [More Information]
  • Mehta, H., Gillies, M., Fraser-Bell, S. (2015). Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema. Therapeutic Advances in Chronic Diseases, 6(5), 234-245. [More Information]

2014

  • Gillies, M., Lim, L., Campain, A., Quin, G., Salem, W., Li, J., Goodwin, S., Aroney, C., McAllister, I., Fraser-Bell, S. (2014). A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema: The BEVORDEX Study. Ophthalmology, 121(12), 2473-2481. [More Information]
  • Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Consequences of long-term discontinuation of vascular endothelial growth factor inhibitor therapy in the patients with neovascular age-related macular degeneration. Acta Ophthalmologica, 92(8), e697-e698. [More Information]
  • Fraser-Bell, S. (2014). Preventing vision loss from advanced age-related macular degeneration. Clinical and Experimental Ophthalmology, 42(5), 409-410. [More Information]
  • Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Reasons for discontinuation of intravitreal vascular endothelial growth factor inhibitors in neovascular age-related macular degeneration. Retina, 34(9), 1774-1778. [More Information]
  • Toniolo, J., Hall, A., Sims, J., Fraser-Bell, S., Khan, J., Younan, C., Kent-Smith, B., Young, S., Paul, E., Lim, L. (2014). Retrospective analysis of the natural history and management of serpiginous choroiditis in Australia and New Zealand. Clinical and Experimental Ophthalmology, 42(7), 656-664. [More Information]

2013

  • Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013). Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical and Experimental Ophthalmology, 41(2), 201-214. [More Information]
  • Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013). Diagnosis and interventions for central serous chorioretinopathy: review and update. Clinical and Experimental Ophthalmology, 41(2), 187-200. [More Information]
  • Karim, R., Sykakis, E., Lightman, S., Fraser-Bell, S. (2013). Interventions for the treatment of uveitic macular edema: a systematic review and meta analysis. Clinical Ophthalmology, 7, 1109-1144. [More Information]

2012

  • Rajendram, R., Fraser-Bell, S., Kaines, A., Michaelides, M., Hamilton, R., Degli Esposti, S., Peto, T., Egan, C., Bunce, C., Leslie, R., et al (2012). A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema: 24-Month Data: Report 3. Archives of Ophthalmology, 130(8), 972-979. [More Information]
  • Salem, W., Fraser-Bell, S., Gillies, M. (2012). Clinical development of new treatments for diabetic macular oedema. Clinical and Experimental Optometry, 95(3), 297-305. [More Information]

2011

  • Fung, A., Azar, D., Fraser-Bell, S., McCluskey, P., Grigg, J. (2011). Ockham's razor revisited: decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension. BMJ Case Reports, 2011, bcr0520103030-bcr0520103030. [More Information]
  • Fung, A., Azar, D., Fraser-Bell, S., McCluskey, P., Grigg, J. (2011). Ockham's razor revisited: Decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension. BMJ Case Reports, 2011 (17 February 2011). [More Information]
  • Atan, D., Fraser-Bell, S., Plskova, J., Kuffova, L., Hogan, A., Tufail, A., Kilmartin, D., Forrester, J., Bidwell, J., Dick, A., et al (2011). Punctate inner choroidopathy and multifocal choroiditis with panuveitis share haplotypic associations with IL10 and TNF loci. Investigative Ophthalmology and Visual Science, 52(6), 3573-3581. [More Information]
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 1. Australian Doctor, 22, 27-32.
  • Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 2. Australian Doctor, 29, 25-32.

2010

  • Michaelides, M., Kaines, A., Hamilton, R., Fraser-Bell, S., Rajendram, R., Quhill, F., Boos, C., Xing, W., Egan, C., Peto, T., et al (2010). A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology, 117(6), 1078-1086. [More Information]
  • Atan, D., Fraser-Bell, S., Plskova, J., Kuffova, L., Hogan, A., Tufail, A., Kilmartin, D., Forrester, J., Bidwell, J., Dick, A., et al (2010). Cytokine polymorphism in noninfectious uveitis. Investigative Ophthalmology and Visual Science, 51(8), 4133-4142. [More Information]
  • Michaelides, M., Fraser-Bell, S., Hamilton, R., Kaines, A., Egan, C., Bunce, C., Peto, T. (2010). Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1. Retina: the Journal of Retinal and Vitreous Diseases, 30(5), 781-786. [More Information]
  • Fraser-Bell, S., Choudhury, F., Klein, R., Azen, S., Varma, R. (2010). Ocular Risk Factors for Age-Related Macular Degeneration: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 149(5), 735-740. [More Information]
  • Essex, R., Wong, J., Fraser-Bell, S., Sandbach, J., Tufail, A., Bird, A., Dowler, J. (2010). Punctate inner choroidopathy: Clinical Features and outcomes. Archives of Ophthalmology, 128(8), 982-987. [More Information]

2009

  • Hooper, C., Lamoureux, E., Lim, L., Fraser-Bell, S., Yeoh, J., Harper, C., Keeffe, J., Guymer, R. (2009). Cataract surgery in high-risk age-related macular degeneration: A randomized controlled trial. Clinical and Experimental Ophthalmology, 37(6), 570-576. [More Information]

2008

  • Fraser-Bell, S., Pavesio, C. (2008). Advances in the treatment of intermediate and posterior uveitis. Expert Review of Ophthalmology, 3(4), 449-456. [More Information]
  • Fraser-Bell, S., Wu, J., Klein, R., Azen, S., Hooper, C., Foong, A., Varma, R. (2008). Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study. American Journal of Ophthalmology, 145(2), 308-316. [More Information]
  • Fraser-Bell, S., Kaines, A., Hykin, P. (2008). Update on treatments for diabetic macular edema. Current Opinion in Ophthalmology, 19(3), 185-189. [More Information]

2007

  • Fung, A., Fraser-Bell, S., Ojaimi, E., Sutton, G. (2007). In vivo confocal microscopy and polarizing microscopy of the cornea in a patient with nephropathic cystinosis. Clinical and Experimental Ophthalmology, 35, 292-293. [More Information]

2006

  • Hooper, C., Fraser-Bell, S., Farinelli, A., Grigg, J. (2006). Complicated hyphaema: think sickle. Clinical and Experimental Ophthalmology, 34(4), 377-378. [More Information]
  • Fraser-Bell, S., Wu, J., Klein, R., Azen, S., Varma, R., Latino Eye Study Group, L. (2006). Smoking, Alcohol Intake, Estrogen Use, and Age-related Macular Degeneration in Latinos: the Los Angeles Latino Eye Study. American Journal of Ophthalmology, 141(1), 79-87. [More Information]

2005

  • De Moura, C., Fraser-Bell, S., Stout, A., Labree, L., Nilfors, M., Varma, R. (2005). Experience with the Baerveldt glaucoma implant in the management of pediatric glaucoma. American Journal of Ophthalmology, 139(5), 847-854. [More Information]
  • Shufelt, C., Fraser-Bell, S., Ying-Lai, M., Torres, M., Varma, R., Los Angeles Latino Eye Study Group, -. (2005). Refractive error, ocular biometry, and lens opalescence in an adult population: The Los Angeles Latino Eye Study. Investigative Ophthalmology and Visual Science, 46(12), 4450-4460. [More Information]
  • Fraser-Bell, S., Donofrio, J., Wu, J., Klein, R., Azen, S., Varma, R., Los Angeles Latino Eye Study Group, -. (2005). Sociodemographic factors and age-related macular degeneration in Latinos: The Los Angeles Latino Eye Study. American Journal of Ophthalmology, 139(1), 30-38. [More Information]

2004

  • Fraser-Bell, S., Ying-Lai, M., Klein, R., Varma, R., Los Angeles Latino Eye Study Group, -. (2004). Prevalence and Associations of Epiretinal Membranes in Latinos: The Los Angeles Latino Eye Study. Investigative Ophthalmology and Visual Science, 45(6), 1732-1736. [More Information]
  • Varma, R., Fraser-Bell, S., Tan, S., Klein, R., Azen, S., Los Angeles Latino Eye Study Group, -. (2004). Prevalence of age-related macular degeneration in Latinos: The Los Angeles Latino eye study. Ophthalmology, 111(7), 1288-1297. [More Information]

2003

  • Guzowski, M., Fraser-Bell, S., Rochtchina, E., Wang, J., Mitchell, P. (2003). Asymmetric refraction in an older population: the Blue Mountains Eye Study. American Journal of Ophthalmology, 136(3), 551-553. [More Information]
  • Fraser-Bell, S., Varma, R. (2003). Eye Disease in Latinos. International Ophthalmology Clinics, 43(4), 79-89. [More Information]
  • Fraser-Bell, S., Guzowski, M., Rochtchina, E., Wang, J., Mitchell, P. (2003). Five-year cumulative incidence and progression of epiretinal membranes. Ophthalmology, 110(1), 34-40. [More Information]

To update your profile click here. For support on your academic profile contact .